We’re excited to share that Merck’s new monoclonal antibody, Enflonsia™, is now part of the CPP portfolio. This addition reflects the…
RSV
August 4, 2025
![Sanofi Beyfortus Webinar]()
RSV season is approaching, are you ready to protect your youngest patients? We’re excited to share an upcoming 45-minute educational webinar hosted…
February 17, 2025
![RSV immunizations]()
RSV is a significant concern for infants and young children, often leading to hospitalizations. Surveys by the AAP show that…
December 12, 2024
![CDC 2025 schedule]()
The Centers for Disease Control and Prevention (CDC) has released the 2025 immunization schedules for child & adolescent and adults. Below…
November 26, 2024
![Holiday season]()
The holiday season is a time for gathering with loved ones, but it also coincides with the peak of flu,…
October 16, 2024
![CDC Healthcare Toolkit]()
The Centers for Disease Prevention and Control (CDC) are helping health care providers prepare their patients for the fall and…
September 11, 2024
![Phreesia RSV Season]()
As the colder months approach, so does respiratory season, bringing with it a surge in illnesses like the flu, COVID-19,…
January 17, 2024
![Flu COVID and RSV]()
With the new year beginning, the country is experiencing a surge in respiratory cases of the flu, COVID-19, and RSV….
December 6, 2023
![RSV for infants]()
Did you know there is now protection from RSV for infants for the 2023-2024 RSV season? There are two new…
August 30, 2023
![RSV Updates]()
RSV MONOCLONAL ANTIBODY (INFANTS) On August 3rd, the ACIP voted unanimously and recommended the use of Sanofi and AstraZeneca’s Beyfortus™,…